Diagnostic Methods in Biotechnology: ELISA
What is the role of ELISA in modern immunodiagnostics? Discover the fundamental principles, limitations, and strategic advantages of this antibody-based detection technique.
Modern diagnostic methods: What is the ELISA technique and how does it work?
In clinical laboratories and biotechnology research, the detection of proteins, antibodies, antigens, and hormones is critical for the early diagnosis of diseases.
The identification of such biomolecules using “antibodies” is called immunodiagnostics.
One of the best-known immunodiagnostic methods is the ELISA technique.
The Western blot, which we cover in a separate article, also stands as a prominent example of this antibody-based approach.
What is the ELISA?
ELISA is an acronym, and the full name of the technique is Enzyme-Linked Immunosorbent Assay.
It has two basic components:
As the name implies, enzymes are used in this technique.
However, while enzymes act as signal generators, antibodies serve as the detecting elements.
It works as follows:
Biomolecules in the clinical sample are captured by antibodies.
Signal generation occurs through the action of enzymes.
Applications of the ELISA technique
Clinical Diagnostics: Routinely used to diagnose infectious diseases, monitor thyroid or pregnancy hormones, and screen for common allergens like milk, peanuts, and gluten.
Life Science Research: Employed across all fields of biology to quantify proteins and validate novel biomarkers.
Common Misconception: People often equate the term "ELISA test" exclusively with HIV testing. While ELISA is indeed a primary screening tool for HIV antigens and antibodies, it is actually a universal technology platform capable of testing for thousands of different molecular targets.
What are the advantages of the ELISA?
The most important reasons why the ELISA method is widely preferred worldwide are as follows:
High Specificity: Since it is based on the interaction between antigen and antibody molecules, specificity is very high.
High Sensitivity: Sensitivity is high, particularly due to the use of enzymes for signal amplification.
Quantitative: Its most important advantage is the ability to determine the numerical concentrations of the target biomolecule.
High-Throughput: 96 samples can be analyzed simultaneously on 96-well plates; therefore, it is ideal for measuring multiple samples.
What are the disadvantages and limitations of the ELISA?
Risk of Cross-Reaction (False Positives): Although this risk is low because standard protocols are followed for clinical diagnoses, it is particularly important to properly optimize the protocol in research laboratories. For example, adjusting the amounts of the antibody—the detection molecule—and the blocking processes, etc. Even if optimization is performed correctly, false positives may still occur in clinical settings against similar antigens; that is, similar antigens may produce a signal resembling that of the target antigen.
Challenges and Costs of Antibody Production: Since antibodies are used as detection molecules in the ELISA technique, they are a key component. Therefore, the quality and cost of antibodies affect the quality and cost of the test.
Practical applications in Rapdi Biotech
At Rapdi Biotech, we integrate this assay platform into our advanced molecular workflows.
Our core practical applications include:
Antibody Alternatives: Focusing our core research on the custom selection of high-affinity aptamer molecules tailored for diverse molecular targets.
ALISA & ELASA Platforms: Developing advanced ELISA modifications that utilize synthetic aptamers depending on the specific scope of the assay.
Target Selection Services: Structuring custom selection protocols for unique targets of interest to optimize laboratory assay sensitivity.
If you would like to have aptamers selected for a target of interest, please feel free to contact us at Rapdi Biotech at any time.
References:
Amnuaycheewa, P., Niemann, L., Goodman, R. E., Baumert, J. L., & Taylor, S. L. (2022). Challenges in gluten analysis: A comparison of four commercial sandwich ELISA kits. Foods, 11(5), 706.
Domsicova, M., Korcekova, J., Poturnayova, A., & Breier, A. (2024). New insights into aptamers: An alternative to antibodies in the detection of molecular biomarkers. International Journal of Molecular Sciences, 25(13), 6833.
Kazerouni, F., & Amirrasouli, H. (2012). Performance characteristics of three automated immunoassays for thyroid hormones. Caspian Journal of Internal Medicine, 3(2), 400–404.
Konstantinou, G. N. (2017). Enzyme-linked immunosorbent assay (ELISA). Methods in Molecular Biology, 1592, 79–94.
Lu, Y., & Fu, T. J. (2024). Evaluation of ELISA test kits for detection of milk protein in frying oil treated at different temperatures. Journal of Food Protection, 87(2), 100211.
Pandey, A. K., Varshney, R. K., Sudini, H. K., & Pandey, M. K. (2019). An improved enzyme-linked immunosorbent assay (ELISA) based protocol using seeds for detection of five major peanut allergens Ara h 1, Ara h 2, Ara h 3, Ara h 6, and Ara h 8. Frontiers in Nutrition, 6, 68.
Saville, R. D., Constantine, N. T., Cleghorn, F. R., Jack, N., Bartholomew, C., Edwards, J., Gomez, P., & Blattner, W. A. (2001). Fourth-generation enzyme-linked immunosorbent assay for the simultaneous detection of human immunodeficiency virus antigen and antibody. Journal of Clinical Microbiology, 39(7), 2518–2524.
Taneja, V., Goel, M., Shankar, U., Kumar, A., Khilnani, G. C., Prasad, H. K., Prasad, G. B. K. S., Gupta, U. D., & Sharma, T. K. (2020). An aptamer linked immobilized sorbent assay (ALISA) to detect circulatory IFN-α, an inflammatory protein among tuberculosis patients. ACS Combinatorial Science, 22(11), 656–666.
Toh, S. Y., Citartan, M., Gopinath, S. C. B., & Tang, T. H. (2015). Aptamers as a replacement for antibodies in enzyme-linked immunosorbent assay. Biosensors and Bioelectronics, 64, 392–403.
Urio, L. J., Mohamed, M. A., Mghamba, J., Abade, A., & Aboud, S. (2015). Evaluation of HIV antigen/antibody combination ELISAs for diagnosis of HIV infection in Dar Es Salaam, Tanzania. Pan African Medical Journal, 20, 196. doi.org
Zubair, M., Singh, C., & Farhana, A. (2026). Enzyme-linked immunosorbent assay (ELISA). StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK555922/
Disclaimer:
The information provided in this article is for educational and informational purposes only, based on current scientific literature. It does not constitute medical advice, diagnosis, or treatment. For any medical concerns or diagnostic needs, always consult with a qualified healthcare professional.